Aneurysm Devices In The Regulatory Spotlight: US FDA Panel Meeting Set For March

The agency scheduled a Neurological Devices Panel meeting for March 1 to consider appropriate clinical design and data expectations for intracranial aneurysm devices.

Medical devices to treat intracranial aneurysms will get attention by a panel convened by US FDA on March 1. The agency's Neurological Devices Panel will meet then to discuss clinical requirements for this class of devices, FDA said in a Dec. 27 meeting notice.

Multiple companies are developing interventional devices to treat aneurysms and hemorrhagic stroke, with some products, including Medtronic PLC's Pipeline...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Approvals

More from Policy & Regulation